The global Cancer Immunotherapy Market was valued at USD 153.3 billion in 2025 and is projected to grow from USD 166.4 billion in 2026 to USD 305.8 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.3% in 2025, primarily driven by the increasing prevalence of cancer, continuous innovation in...

The global Keytruda Market was valued at USD 31.4 billion in 2025 and is projected to grow from USD 32.7 billion in 2026 to USD 25.0 billion by 2033, registering a CAGR of -3.8% from 2026 to 2033. While Keytruda (pembrolizumab) remains one of the most successful immunotherapy drugs globally, the market is expected to face headwinds over the forecast period due to patent expiration,...

The global Pharmaceutical CRO Market size was valued at USD 45.3 billion in 2025 and is projected to grow from USD 48.5 billion in 2026 to USD 83.3 billion by 2033, expanding at a CAGR of 8.0% from 2026 to 2033. Asia Pacific accounted for the largest market share of 26.4% in 2025, driven by increasing clinical research activities, expanding pharmaceutical outsourcing, lower...

The global healthcare and oncology sectors are witnessing rapid advancements in cancer therapeutics, particularly in the treatment of rare and aggressive blood cancers such as mantle cell lymphoma (MCL). Increasing awareness regarding early diagnosis, advancements in targeted therapies, and growing investments in oncology research are significantly contributing to industry expansion. The rising...

The stomach cancer therapeutics market is experiencing significant growth as healthcare providers and pharmaceutical companies focus on developing more effective treatment options for gastric cancer. Stomach cancer remains one of the leading causes of cancer-related mortality worldwide, creating substantial demand for advanced therapeutics that improve survival rates and patient outcomes....

GLOBAL SUPPLY CHAIN DISRUPTION ALERT Escalating tensions around the Strait of Hormuz and Red Sea are disrupting key global trade routes, putting energy, chemicals, and logistics supply chains at risk. Rising freight costs, supply delays, and price volatility are impacting industries worldwide. 👉 Request a Sample Report for real-time market impact analysis, price outlooks, and...

The US Immunotherapy Drugs Market represents the largest share of the global market, driven by a high prevalence of cancer and autoimmune disorders, substantial healthcare spending, and strong investments in biopharmaceutical research and development. The country is home to many leading pharmaceutical and biotechnology companies actively developing innovative immunotherapy treatments, including...

Significant progress in cancer genomics and immunotherapy is accelerating the growth of the Neoantigens Market. Neoantigens are mutation-derived antigens found only in cancer cells, making them valuable targets for personalized treatment strategies. Increasing funding for immuno-oncology research, technological breakthroughs in genome sequencing, and the expanding use of precision medicine are...